Cargando…

Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection

Extreme-drug-resistant (XDR) Acinetobacter baumannii is a rapidly emerging pathogen causing infections with unacceptably high mortality rates due to inadequate available treatment. New methods to prevent and treat such infections are a critical unmet medical need. To conduct a rational vaccine disco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Guanpingshen, Lin, Lin, Ibrahim, Ashraf S., Baquir, Beverlie, Pantapalangkoor, Paul, Bonomo, Robert A., Doi, Yohei, Adams, Mark D., Russo, Thomas A., Spellberg, Brad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3254619/ https://www.ncbi.nlm.nih.gov/pubmed/22253723 http://dx.doi.org/10.1371/journal.pone.0029446

Ejemplares similares

Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis
por: Lin, Lin, et al.
Publicado: (2012)

971. The Role of Inflammation and Innate Effectors in Passive Immunization for Acinetobacter baumannii Infections
por: Nielsen, Travis B, et al.
Publicado: (2019)

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
por: Nielsen, Travis B., et al.
Publicado: (2015)

Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) Acinetobacter baumannii HUMC1
por: Luna, Brian M., et al.
Publicado: (2017)

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice
por: Lin, Lin, et al.
Publicado: (2009)

Natural history of Acinetobacter baumannii infection in mice
por: Luna, Brian M., et al.
Publicado: (2019)

Capsule carbohydrate structure determines virulence in Acinetobacter baumannii
por: Talyansky, Yuli, et al.
Publicado: (2021)

Extensively Drug-Resistant Acinetobacter baumannii
por: Doi, Yohei, et al.
Publicado: (2009)

Transcriptome Remodeling of Acinetobacter baumannii during Infection and Treatment
por: Wright, Meredith S., et al.
Publicado: (2017)

Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii
por: Cheng, Jiaqi, et al.
Publicado: (2021)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
por: Wright, Meredith S., et al.
Publicado: (2016)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
por: Yassin, Mohamed H., et al.
Publicado: (2020)

Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts In Vivo Outcomes in Galleria mellonella
por: Miller, Sarah, et al.
Publicado: (2022)

2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains
por: Iovleva, Alina, et al.
Publicado: (2023)

Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace
por: Ramirez, Maria Soledad, et al.
Publicado: (2020)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance
por: Iovleva, Alina, et al.
Publicado: (2022)

In Vitro Activity of Rifabutin and Rifampin against Antibiotic-Resistant Acinetobacter baumannii, Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Klebsiella pneumoniae
por: Lee, Bosul, et al.
Publicado: (2021)

Ly6G-mediated depletion of neutrophils is dependent on macrophages
por: Bruhn, Kevin W., et al.
Publicado: (2015)

Characterization of Extremely Drug-Resistant and Hypervirulent Acinetobacter baumannii AB030
por: Singh, Manu, et al.
Publicado: (2020)

Comparative Genomic Analysis of Rapid Evolution of an Extreme-Drug-Resistant Acinetobacter baumannii Clone
por: Tan, Sean Yang-Yi, et al.
Publicado: (2013)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Identification of Potential Virulence Factors in the Model Strain Acinetobacter baumannii A118
por: Ramirez, Maria S., et al.
Publicado: (2019)

Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections
por: Watkins, Richard R, et al.
Publicado: (2023)

Multidrug-Resistant Acinetobacter baumannii in Jordan
por: Al-Tamimi, Mohammad, et al.
Publicado: (2022)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates
por: Lu, Peggy, et al.
Publicado: (2023)

Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii
por: Singh, Jennifer K., et al.
Publicado: (2019)

Advances in automated techniques to identify Acinetobacter calcoaceticus–Acinetobacter baumannii complex
por: Bagudo, Ahmad Ibrahim, et al.
Publicado: (2020)

Rapid Replacement of Acinetobacter baumannii Strains Accompanied by Changes in Lipooligosaccharide Loci and Resistance Gene Repertoire
por: Adams, Mark D., et al.
Publicado: (2019)

A Nutrient-limited Screen Unmasks Rifabutin Hyperactivity for XDR Acinetobacter baumannii
por: Luna, B., et al.
Publicado: (2020)

Prevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
por: Aliakbarzade, Katayun, et al.
Publicado: (2014)

Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
por: Powers, Rachel A., et al.
Publicado: (2014)

The Iron Content of Human Serum Albumin Modulates the Susceptibility of Acinetobacter baumannii to Cefiderocol
por: Escalante, Jenny, et al.
Publicado: (2023)

Recent Advances in the Treatment of Mucormycosis
por: Spellberg, Brad, et al.
Publicado: (2010)

Cryo-Electron Microscopy Structure of an Acinetobacter baumannii Multidrug Efflux Pump
por: Su, Chih-Chia, et al.
Publicado: (2019)

Interaction of Acinetobacter baumannii with Human Serum Albumin: Does the Host Determine the Outcome?
por: Pimentel, Camila, et al.
Publicado: (2021)

NtrBC Selectively Regulates Host-Pathogen Interactions, Virulence, and Ciprofloxacin Susceptibility of Pseudomonas aeruginosa
por: Alford, Morgan A., et al.
Publicado: (2021)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dvmrquvf862hsjd3nrb6kmeg5s